Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2022 Apr 20;3(2):e135.
doi: 10.1002/mco2.135. eCollection 2022 Jun.

Erratum

No authors listed
Published Erratum

Erratum

No authors listed. MedComm (2020). .

Abstract

[This corrects the article DOI: 10.1002/mco2.124.].

PubMed Disclaimer

Figures

FIGURE 5
FIGURE 5
Schematic of STAT3 signaling in tumor microenvironment (TME). STAT3 activation has the ability in affecting TME via up‐ or downregulating downstream molecules and promoting tumor cell proliferation and survival, angiogenesis, immune evasion as the result. The functions of natural killer cell and dendritic cell in antigen presentation and target cell recognition are inhibited. While macrophage polarization toward M2‐like endotype and the immune checkpoint expression and proliferation of myeloid‐derived suppressor cell, cancer‐associated fibroblasts, and regulatory T‐cell are promoted by phosphorylated STAT3
See this image and copyright information in PMC

Erratum for

  • STAT3 pathway in cancers: Past, present, and future.
    Wang HQ, Man QW, Huo FY, Gao X, Lin H, Li SR, Wang J, Su FC, Cai L, Shi Y, Liu B, Bu LL. Wang HQ, et al. MedComm (2020). 2022 Mar 23;3(2):e124. doi: 10.1002/mco2.124. eCollection 2022 Jun. MedComm (2020). 2022. PMID: 35356799 Free PMC article. Review.

References

    1. Wang H‐Q, Man Q‐W, Huo F‐Y, et al. STAT3 pathway in cancers: Past, present, and future. MedComm. 2022;3:e124. 10.1002/mco2.124 - DOI - PMC - PubMed

Publication types